Does Dr. FAITH ABODUNRIN have financial conflicts of interest?

Dr. FAITH ABODUNRIN (MD) has received a total of $457 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $457 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. FAITH ABODUNRIN?

According to CMS Open Payments data, Dr. FAITH ABODUNRIN received funding from ASTRAZENECA PHARMACEUTICALS ($120), E.R. SQUIBB & SONS, L.L.C ($111), and SEAGEN ($102).

Does Dr. FAITH ABODUNRIN receive research grants or speaking fees?

Dr. FAITH ABODUNRIN has received $457 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. FAITH ABODUNRIN

MDReal-Time Hydrated

Specialty: Internal Medicine, Hematology & Oncology

Practice Location: CHICAGO, IL 60637

NPI Number: 1437768769

LIFETIME INDUSTRY VALUE

$457

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ABODUNRIN is a verified Internal Medicine, Hematology & Oncology practitioner based in CHICAGO, IL.

Between 2021 and 2024, Dr. ABODUNRIN had an overall industry promotional and research financial footprint of $457 as recorded in the federal CMS Open Payments database.

$457 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABODUNRIN's primary funding source is ASTRAZENECA PHARMACEUTICALS, which accounts for $120 (representing 26.2% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ASTRAZENECA PHARMACEUTICALS

Rank 1

$120

26.2%

E.R. SQUIBB & SONS, L.L.C

Rank 2

$111

24.3%

SEAGEN

Rank 3

$102

22.3%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.